Mutations on codon 132 or 172 of the IDH1 and IDH2 genes, respectively, results in “neo-enzymatic activity” with the production of the novel oncometabolite 2-hydroxyglutarate [11] causing widespread methylation of the tumour cell DNA [55] and altered regulation of histone methylation [9]. Here, IDH1 is linked to neoplasm.